Teva Pharmaceutical Industries Ltd (MEX:TEVA)
MXN 378 4 (1.07%) Market Cap: 420.47 Bil Enterprise Value: 755.29 Bil PE Ratio: 0 PB Ratio: 3.29 GF Score: 42/100

Q2 2019 Teva Pharmaceutical Industries Ltd Earnings Call Transcript

Aug 07, 2019 / 12:00PM GMT
Release Date Price: MXN135 (-11.18%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the Teva Pharmaceutical Industry's 2nd Quarter Financial results (Operator Instructions). I must advise you that this conference is being recorded today, Wednesday, August 7, 2019 and I would now like to hand the call over to your first speaker today, Kevin Mannix, Senior Vice President, Head of Investor Relations.

Kevin C. Mannix
Teva Pharmaceutical Industries Limited - SVP of IR

Good morning everyone, thanks for joining us today to discuss our 2nd Quarter 2019 financial results. We hope you've had an opportunity to review our earning press release. A copy of the release as well as a copy of the slides being presented on this call can be found on our website at www.tevapharm.com as well as through the Teva Investor Relations app.

Please note that the discussion on today's call includes certain non-GAAP measures that are defined by the SEC. Management uses both GAAP financial measures and the disclosed non-GAAP financial measures

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot